Read + Share
Amedeo Smart
Independent Medical Education
Zhao JJ, Yap DWT, Chan YH, Tan BKJ, et al. Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma. J Clin Oncol 2022;40:392-402.PMID: 34860570
Email
LinkedIn
Facebook
Twitter
Privacy Policy